NCT05819463 Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
| NCT ID | NCT05819463 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Swiss Society of Dermatology and Venereology |
| Condition | Atopic Dermatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2022-06-02 |
| Primary Completion | 2032-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2022-06-02 with a primary completion date of 2032-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 12 years * AD according to the UK Working Party's Diagnostic Criteria (28) * Moderate to severe AD as defined by * objective SCORAD \> 20 or IGA ≥ 3 (moderate) or * currently on systemic antiinflammatory therapy for AD or * previous systemic antiinflammatory therapy for AD within past 24 months Exclusion Criteria: * refusal to sign the informed consent form
Contact & Investigator
Dagmar Simon, Prof. Dr. med.
PRINCIPAL INVESTIGATOR
Department of Dermatology, Inselspital
Frequently Asked Questions
Who can join the NCT05819463 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Atopic Dermatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05819463 currently recruiting?
Yes, NCT05819463 is actively recruiting participants. Contact the research team at dagmar.simon@insel.ch for enrollment information.
Where is the NCT05819463 trial being conducted?
This trial is being conducted at Basel, Switzerland, Bern, Switzerland, Buochs, Switzerland, Fribourg, Switzerland and 5 additional locations.
Who is sponsoring the NCT05819463 clinical trial?
NCT05819463 is sponsored by Swiss Society of Dermatology and Venereology. The principal investigator is Dagmar Simon, Prof. Dr. med. at Department of Dermatology, Inselspital. The trial plans to enroll 700 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.